👉 TODAY'S #1 ALERT: Modular Medical, Inc. (MODD) 👈
THE PICK: Modular Medical just officially launched commercial sales and commenced the first shipments of its flagship Pivot™ tubeless insulin patch pump following its comprehensive FDA 510(k) clearance. With a differentiated solution targeting a massive, underserved multi-billion-dollar market, and a freshly strengthened balance sheet via a $3.4 million registered direct offering, MODD could be highly worth watching today.
SOURCE
Let's talk about timing. Right now, the diabetes technology market is massive, yet an estimated 70% of insulin-dependent adults in the US still rely on multiple daily injections. Why? Because existing market solutions are either too complicated to learn or too expensive to adopt. Modular Medical specifically terms this massive, untapped demographic the "almost-pumpers." This represents an wide-open, multi-billion-dollar commercial opportunity. Modular Medical just announced the official commercial availability of Pivot this week on June 24, 2026, marking their formal transition from a development-stage medical device player into a revenue-generating commercial business.
🚨 2 Explosive Catalysts Driving MODD Into Our Focus
Official Commercial Launch & First Shipments Commencing (June 24, 2026)
Modular Medical officially announced the commercial availability of the Pivot tubeless insulin patch pump, with first shipments moving out this week. This is a transformational milestone that transitions the company into an active, revenue-generating enterprise targeting top-tier metropolitan markets. SOURCE
Full US FDA 510(k) Clearance Granted
The Pivot pump secured its official clearance from the US FDA. This represents comprehensive regulatory validation. With a massive target market of patients tired of multiple daily manual injections, MODD now has a cleared regulatory runway to actively capture market share from legacy, overly complex pump competitors. SOURCE
⚡ The Custom Insulin Gap: A Multi-Billion Dollar Market With No Simple Solution
The global diabetes technology market exceeds $11 billion in active valuation, with the specific "almost-pumper" segment accounting for billions in untapped potential in the US alone. With only one other fully electronic tubeless pump currently occupying the US marketplace, the entry of the Pivot pump brings a critically needed alternative. It is intentionally engineered to eliminate the learning curve, making top-tier continuous insulin delivery simple, affordable, and accessible. SOURCE
💰 WHAT STANDS OUT: The Pivot pump uses a highly specific two-part architecture. By separating the high-capacity 3 mL reservoir from the underlying mechanics, it provides patients with greater volume capacity than standard alternatives while minimizing environmental and economic waste. It is a platform explicitly designed to look, feel, and operate with the simplicity of a wearable patch, freeing the patient from the physical burden of extensive tubing and the cognitive burden of complex programming interfaces. SOURCE
📍 Modular Medical, Inc.: The Next Generation of Patient-Centric Insulin Delivery
Modular Medical, Inc. is a commercial-stage medical device company based out of San Diego, California, focused on designing insulin delivery systems that completely eliminate the historical trade-off between technical efficacy and lifestyle complexity. Using its deep portfolio of patented technologies, the company’s mission is to make high-quality, continuous pump therapy accessible to the millions of type 1 and type 2 diabetics who currently refuse standard pumps due to cost or excessive complexity. SOURCE
Regards,
Editor @ Signal Stocks
DISCLAIMER: SPONSORED CONTENT!
PAID ADVERTISEMENT - MANDATORY SECURITIES DISCLOSURE AND DISCLAIMER
I. CAMPAIGN DETAILS
Publisher: Signal Media LLC ("Publisher")
Advertiser: Bullish Media LLC
Compensation to Publisher: $6,000 USD
Campaign Period: 06/26/2026 – 06/26/2026
Subject Issuer: $MODD ( ▲ 19.9% ) - Modular Medical, Inc.
II. COMPENSATION AND PAYMENT CHAIN
The Publisher received $6,000 USD in cash from Bullish Media LLC ("Bullish Media"), before the deduction of any applicable bank wire, PayPal, Wise, or electronic payment processing fees, in exchange for the publication and dissemination of the Information (as defined herein). Bullish Media LLC, in turn, received funding acting on behalf of and with funding provided by the Issuer. All compensation received is strictly cash. Neither the Publisher nor Bullish Media LLC received any equity compensation, stock options, warrants, or securities-based consideration of any kind from the Issuer or any intermediary.
This material may be distributed across platforms including but not limited to email newsletters, YouTube, X (formerly Twitter), TikTok, Instagram, StockTwits, Reddit, Discord, Telegram, WhatsApp, iMessage, SMS, and other social media or online publication channels.
III. CONFLICTS OF INTEREST
The Publisher is not objective or independent. The publication of this Information involves actual and material conflicts of interest, including:
The Publisher is compensated exclusively to publish favorable information about the Issuer and does not publish negative, adverse, or unfavorable information because it is not paid to do so;
The Publisher is paid to encourage others, including you, to purchase the Issuer's securities; and
While this advertisement encourages the purchase of the Issuer's shares, the Issuer, its founders, insiders, officers, directors, affiliates, and control persons own substantial blocks of the Issuer's stock and currently intend to sell, and are highly likely to actively execute sales of, those shares concurrently with the publication of this promotional campaign.
Special Note on Market Dynamics: This campaign may profile companies characterized as "low-float runners." Securities with a low public float are subject to extreme pricing volatility, rapid fluctuations in volume, and heightened susceptibility to artificial inflation or dramatic downward corrections.
This active and concurrent insider selling will likely cause the Issuer's stock price to decline, dramatically reducing the price at which investors can sell their shares. Investors who purchase the Issuer's shares during this promotional campaign will likely pay inflated prices and experience losses, while the Issuer and its insiders make substantial profits.
IV. NO WARRANTIES
The Publisher makes no warranty or representation of any kind, express or implied, regarding the Information, including its completeness, accuracy, truthfulness, or reliability. The Information is provided strictly on an "AS IS" and "AS AVAILABLE" basis. The Publisher does not verify, confirm, or independently validate any portion of the Information and conducts no due diligence or research of any kind with respect to the Issuer or the Information. The Publisher and Bullish Media LLC expressly disclaim all liability for any direct, indirect, incidental, special, punitive, or consequential damages arising from your use of or reliance upon the Information.
V. NOT INVESTMENT ADVICE
The Publisher is not, and does not act in the capacity of, any of the following, and is not qualified to do so:
An independent advisor, consultant, or fiduciary;
A registered investment adviser or provider of investment advice at the federal or state level;
A licensed broker-dealer or registered representative;
A stock picker, securities researcher, or analyst;
A financial planner or provider of stock recommendations; or
A party making an offer, sale, or solicitation to purchase securities.
Nothing in this advertisement constitutes personalized investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. Investing in micro-cap, low-float, or promotional equities involves an extraordinary degree of speculative risk and extreme price and volume volatility. You must be fully prepared to lose your entire investment.
VI. MANDATORY DUE DILIGENCE
Investors must not rely upon this Information for any purpose. Prior to making any investment decision, you are strongly urged to:
Consult a licensed financial advisor, attorney, and tax advisor;
Review all publicly available filings, disclosures, short sale positions, and risk factors pertaining to the Issuer at www.sec.gov and www.otcmarkets.com; and
Conduct your own thorough, independent investigation of the Issuer's financial condition, operations, management, trading history, and any other information material to an investment decision.